Today: 30 June 2026
Shopify (SHOP) stock price ends flat after layoffs report — what to watch before Monday’s open
24 January 2026
2 mins read

Shopify (SHOP) stock price ends flat after layoffs report — what to watch before Monday’s open

New York, Jan 23, 2026, 20:12 EST — Market closed

  • Shopify shares ended the day 0.2% higher at $137.89 following a volatile week
  • Shopify reportedly reduced headcount in its partnerships division as part of a broader restructuring effort
  • Traders are zeroing in on the Fed’s Jan. 27-28 meeting, watching closely for rate signals that could impact high-growth tech

Shopify Inc shares closed Friday up 0.2% at $137.89, recovering slightly after steep declines earlier in the week. Investors digested news of job cuts alongside a wider reevaluation of high-growth tech stocks.

The modest shift is notable since Shopify has behaved like a rate-sensitive growth stock this month, with buyers pulling back whenever the market turns cautious. With the U.S. central bank meeting looming next week, traders have been trimming exposure to companies whose narratives are rooted in the distant future.

The shake-up in partnerships introduces a new layer of uncertainty. Shopify’s network of app developers, agencies, and service providers plays a key role in attracting merchants to its platform, so any shift in that ecosystem is closely scrutinized.

The stock has dropped roughly 12% since last Friday’s close, despite a late-week pause on Friday.

Canadian tech news site BetaKit reported Thursday that Shopify has cut jobs again, this time targeting its partnerships team. Employees shared on LinkedIn that their positions were axed amid a company restructuring. Shopify has not revealed the number of layoffs involved, the report noted.

On Jan. 21, Atlee Clark, Shopify’s vice president of partnerships, posted on LinkedIn about the company “starting a new chapter” for its partners. He highlighted efforts to “bring product, partnerships, and community-building closer together” with a focus on creating “low-friction systems.” LinkedIn

Shopify is pushing what it calls “agentic commerce” — shopping experiences where AI guides users to products and then hands off to checkout. Earlier this month, it announced an open “Universal Commerce Protocol,” developed alongside Google. Shopify executive Vanessa Lee highlighted the company’s “history of building checkouts for millions” as it promotes the new standard. Google’s Ashish Gupta described the protocol as a shared framework for the broader ecosystem. Shopify

Risk appetite was muted on Friday. The S&P 500 and Nasdaq managed small gains, yet investors remained wary following a sharp decline in Intel shares, alongside ongoing geopolitical tensions and tariff discussions, according to a Reuters report.

Shopify’s immediate challenge is proving if its internal streamlining and fresh distribution strategies will drive quicker merchant growth and better margins, or if partner channel disruptions hold back progress. Investors are quick to react, with little tolerance for missteps.

The downside scenario is straightforward: interest rates remain elevated, ad and consumer spending weaken, and investors continue to discount long-duration tech cash flows. In this environment, even solid product announcements may fail to boost the stock sustainably.

Traders are eyeing the Federal Reserve’s meeting on Jan. 27-28 for signals on interest rates — a crucial factor for growth stocks like Shopify.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Exxon Mobil stock price rises after-hours as XTO shops $1 billion Eagle Ford assets ahead of Q4 results
Previous Story

Exxon Mobil stock price rises after-hours as XTO shops $1 billion Eagle Ford assets ahead of Q4 results

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop